Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Increased Patient Activation Is Associated with Fewer Emergency Room Visits and Hospitalizations for Pain in Adults with Sickle Cell Disease.

Cronin RM, Dorner TL, Utrankar A, Allen W, Rodeghier M, Kassim AA, Jackson GP, DeBaun MR.

Pain Med. 2018 Oct 16. doi: 10.1093/pm/pny194. [Epub ahead of print]

PMID:
30329108
2.

Cost-effectiveness of adenotonsillectomy in reducing obstructive sleep apnea, cerebrovascular ischemia, vaso-occlusive pain, and ACS episodes in pediatric sickle cell disease.

Tripathi A, Jerrell JM, Stallworth JR.

Ann Hematol. 2011 Feb;90(2):145-50. doi: 10.1007/s00277-010-1048-4. Epub 2010 Aug 17.

PMID:
20714723
3.

Role of self-care in sickle cell disease.

Matthie N, Jenerette C, McMillan S.

Pain Manag Nurs. 2015 Jun;16(3):257-66. doi: 10.1016/j.pmn.2014.07.003. Epub 2014 Oct 31.

4.

Sickle Cell Disease.

Bender MA.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
2003 Sep 15 [updated 2017 Aug 17].

5.

Association of care in a medical home and health care utilization among children with sickle cell disease.

Raphael JL, Rattler TL, Kowalkowski MA, Brousseau DC, Mueller BU, Giordano TP.

J Natl Med Assoc. 2013 Summer;105(2):157-65.

6.

A Qualitative Study of Chronic Pain and Self-Management in Adults with Sickle Cell Disease.

Matthie N, Ross D, Sinha C, Khemani K, Bakshi N, Krishnamurti L.

J Natl Med Assoc. 2018 Sep 25. pii: S0027-9684(18)30215-3. doi: 10.1016/j.jnma.2018.08.001. [Epub ahead of print]

PMID:
30266214
7.

Saudi SCD patients' symptoms and quality of life relative to the number of ED visits.

Ahmed AE, Alaskar AS, McClish DK, Ali YZ, Aldughither MH, Al-Suliman AM, Malhan HM.

BMC Emerg Med. 2016 Aug 20;16(1):30. doi: 10.1186/s12873-016-0096-z.

8.

How patients' self-disclosure about sickle cell pain episodes to significant others relates to living with sickle cell disease.

Derlega VJ, Janda LH, Miranda J, Chen IA, Goodman BM 3rd, Smith W.

Pain Med. 2014 Sep;15(9):1496-507. doi: 10.1111/pme.12535. Epub 2014 Aug 26.

PMID:
25159869
9.

Care Coordination for Children With Sickle Cell Disease: A Longitudinal Study of Parent Perspectives and Acute Care Utilization.

Rattler TL, Walder AM, Feng H, Raphael JL.

Am J Prev Med. 2016 Jul;51(1 Suppl 1):S55-61. doi: 10.1016/j.amepre.2016.01.023.

10.

Symptomatic Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization by Patients with SCD.

Yu T, Campbell T, Ciuffetelli I, Haywood C Jr, Carroll CP, Resar L, Strouse JJ, Lanzkron S.

South Med J. 2016 Sep;109(9):519-24. doi: 10.14423/SMJ.0000000000000512.

11.

Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.

Badawy SM, Thompson AA, Lai JS, Penedo FJ, Rychlik K, Liem RI.

Health Qual Life Outcomes. 2017 Jul 5;15(1):136. doi: 10.1186/s12955-017-0713-x.

12.

Perceived discrimination in health care is associated with a greater burden of pain in sickle cell disease.

Haywood C Jr, Diener-West M, Strouse J, Carroll CP, Bediako S, Lanzkron S, Haythornthwaite J, Onojobi G, Beach MC; IMPORT Investigators; IMPORT Investigators.

J Pain Symptom Manage. 2014 Nov;48(5):934-43. doi: 10.1016/j.jpainsymman.2014.02.002. Epub 2014 Apr 15.

13.

Somatic symptom burden in adults with sickle cell disease predicts pain, depression, anxiety, health care utilization, and quality of life: the PiSCES project.

Sogutlu A, Levenson JL, McClish DK, Rosef SD, Smith WR.

Psychosomatics. 2011 May-Jun;52(3):272-9. doi: 10.1016/j.psym.2011.01.010.

PMID:
21565599
14.

Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.

Krishnamoorthy P, Alyaarubi S, Abish S, Gale M, Albuquerque P, Jabado N.

Pediatrics. 2006 Aug;118(2):e537-9.

PMID:
16882790
15.

Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit.

Molokie RE, Montminy C, Dionisio C, Farooqui MA, Gowhari M, Yao Y, Suarez ML, Ezenwa MO, Schlaeger JM, Wang ZJ, Wilkie DJ.

Am J Emerg Med. 2018 Jan;36(1):88-92. doi: 10.1016/j.ajem.2017.07.037. Epub 2017 Jul 13.

PMID:
28802541
16.

Sickle-cell pain: advances in epidemiology and etiology.

Smith WR, Scherer M.

Hematology Am Soc Hematol Educ Program. 2010;2010:409-15. doi: 10.1182/asheducation-2010.1.409.

PMID:
21239827
17.

Outpatient pain predicts subsequent one-year acute health care utilization among adults with sickle cell disease.

Ezenwa MO, Molokie RE, Wang ZJ, Yao Y, Suarez ML, Angulo V, Wilkie DJ.

J Pain Symptom Manage. 2014 Jul;48(1):65-74. doi: 10.1016/j.jpainsymman.2013.08.020. Epub 2014 Mar 15.

18.

Characterization of opioid use in sickle cell disease.

Han J, Zhou J, Saraf SL, Gordeuk VR, Calip GS.

Pharmacoepidemiol Drug Saf. 2018 May;27(5):479-486. doi: 10.1002/pds.4291. Epub 2017 Aug 16.

PMID:
28815799
19.

Multicenter COMPACT study of COMplications in patients with sickle cell disease and utilization of iron chelation therapy.

Jordan L, Adams-Graves P, Kanter-Washko J, Oneal PA, Sasane M, Vekeman F, Bieri C, Magestro M, Marcellari A, Duh MS.

Curr Med Res Opin. 2015 Mar;31(3):513-23. doi: 10.1185/03007995.2014.998815. Epub 2014 Dec 31.

PMID:
25495135
20.

An analysis of inpatient pediatric sickle cell disease: Incidence, costs, and outcomes.

Bou-Maroun LM, Meta F, Hanba CJ, Campbell AD, Yanik GA.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26758. Epub 2017 Aug 12.

PMID:
28801954

Supplemental Content

Support Center